Home hospital care for infections: when does it fail?

NCT ID NCT07703995

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 23, 2026 · Updated 4 times

Summary

This study looks back at medical records of adults who were sent home from the emergency department to receive hospital-level care for common infections like pneumonia, urinary tract infections, or skin infections. The goal is to understand why some of these patients end up needing to return to the hospital or die during their home treatment. By analyzing patient characteristics and outcomes, researchers hope to improve the selection process for home hospital care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify which patients are best suited for hospital-at-home care, reducing unnecessary hospital stays and improving patient outcomes.
What could go wrong
This is a retrospective review of medical records, not a controlled experiment, so it can only show associations, not cause and effect. The findings may not apply to other hospitals or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

447 people

The number who actually took part.

Started

Aug 2024

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study description focuses on patients who participated in Model C of the National Health Insurance Administration's Acute Care at Home Pilot Program across three participating medical centers between August 1, 2024, and January 1, 2026. The population comprises individuals initially presenting to the emergency department with any of the target primary acute infections-specifically pneumonia, urinary tract infection, or skin and soft tissue infection(either alone or in combination)- who were subsequently transitioned to the Hospital-at-Home care model.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Enrolled under Model C of the National Health Insurance Administration (NHIA) Acute Care at Home (ACAH) Pilot Program at one of the three participating centers. * Formally assessed and cleared for home care by the specialized interdisciplinary Hospital-at-Home (HaH) team using a standardized screening tool. * Functional status meeting at least one of the following: a Barthel Index score of less than 60, or documented difficulty accessing outpatient care due to the nature of the illness, as assessed by the attending emergency physician. * A primary diagnosis of pneumonia, urinary tract infection (UTI), or skin and soft tissue infection (SSTI), either alone or in combination, confirmed by ICD-10 codes. * Clinical requirement for antimicrobial therapy, including intravenous antibiotic administration. * Written informed consent obtained from the patient or their legal representative during the historical clinical encounter. Exclusion Criteria: * Hemodynamic instability, defined as persistent systolic blood pressure \<90 mmHg despite initial fluid resuscitation, or any clinical requirement for intensive care unit (ICU) level monitoring or care. * Immediate need for inpatient-only medical resources, including immediate surgical intervention, initiation of hemodialysis, or advanced diagnostic procedures not feasible in a home setting. * Unsafe or unsuitable home environment, including absence of adequate caregiver support, hazardous living conditions, or severe cognitive or behavioral conditions that preclude adherence to the home treatment plan.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute infection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chi Mei Medical Center

    Tainan, Tainan, 710033, Taiwan

  • Taipei Medical University Hospital

    Taipei, 110301, Taiwan

  • Wanfang Hospital, Taipei Medical University

    Taipei, 116081, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.